CHEK1 and posterior cortical atrophy: TLK1 is a better druggable target than other kinases of the DDR pathway, such as ATM or Chk1, to reduce general toxicity as ADT selectively increases TLK1B level in PCa cells, which can be easily manipulated using TLK1 specific inhibitors sparing the non-cancerous cells.